To deliver value to its partners, Ionpath is leveraging the MIBI (Multiplexed Ion Beam Imaging) platform in combination with the company’s extensive R&D capabilities, robust deep experience with disease biology, and proprietary set of advanced algorithms for deciphering highly-multiplexed imaging data.  

Ionpath works with our customers from study design through data analysis. The final project results go beyond data and deliverinto actionable insights on differential patient response to treatment and drug mechanism of action.

If you're interested in learning how your organization can partner with Ionpath, please email